Background: Missed oesophageal cancer (MEC) at upper gastrointestinal endoscopy (UGE) is poorly documented. Objective: The objectives of this study were: (1) to assess the rate, predictors and survival of MEC; (2) to compare MEC and non-MEC tumours. Methods: This was a retrospective cohort study conducted at four tertiary centres. Oesophageal cancers (ECs) diagnosed between 2008 and 2015 were included. Patients with a premalignant condition (Barrett, achalasia), prior diagnosis of EC or oesophagogastric junction tumour of gastric origin were excluded. MEC was defined as EC detected within 36 months after negative UGE. Results: 123,395 UGEs were performed during the study period, with 502 ECs being diagnosed (0.4%). A total of 391 ECs were finally included. Overall MEC rate was 6.4% (95% confidence intervals (CI): 4.4-9.3%). The interval between negative and diagnostic UGE was less than 2 years in 84% of the cases. Multivariate analysis showed that a negative endoscopy was associated with proton pump inhibitor (PPI) therapy and less experienced endoscopists. MEC was smaller than non-MEC at diagnosis (25 versus 40 mm, p = 0.021), more often flat or depressed (p = 0.013) and less frequently diagnosed as metastatic disease (p = 0.013). Overall 2-year survival rate was similar for MEC (20%) and non-MEC (24.1%) (p = 0.95). Conclusions: MEC accounted for 6.4% of all ECs and was associated with poor survival. High-quality UGE and awareness of MEC may help to reduce its incidence.
Background: Missed oesophageal cancer (MEC) at upper gastrointestinal endoscopy (UGE) is poorly documented. Objective: The objectives of this study were: (1) to assess the rate, predictors and survival of MEC; (2) to compare MEC and non-MEC tumours. Methods: This was a retrospective cohort study conducted at four tertiary centres. Oesophageal cancers (ECs) diagnosed between 2008 and 2015 were included. Patients with a premalignant condition (Barrett, achalasia), prior diagnosis of EC or oesophagogastric junction tumour of gastric origin were excluded. MEC was defined as EC detected within 36 months after negative UGE. Results: 123,395 UGEs were performed during the study period, with 502 ECs being diagnosed (0.4%). A total of 391 ECs were finally included. Overall MEC rate was 6.4% (95% confidence intervals (CI): 4.4-9.3%). The interval between negative and diagnostic UGE was less than 2 years in 84% of the cases. Multivariate analysis showed that a negative endoscopy was associated with proton pump inhibitor (PPI) therapy and less experienced endoscopists. MEC was smaller than non-MEC at diagnosis (25 versus 40 mm, p = 0.021), more often flat or depressed (p = 0.013) and less frequently diagnosed as metastatic disease (p = 0.013). Overall 2-year survival rate was similar for MEC (20%) and non-MEC (24.1%) (p = 0.95). Conclusions: MEC accounted for 6.4% of all ECs and was associated with poor survival. High-quality UGE and awareness of MEC may help to reduce its incidence.
Authors: Michael K Gibson; Arashinder S Dhaliwal; Nicholas J Clemons; Wayne A Phillips; Katerina Dvorak; Daniel Tong; Simon Law; E Daniel Pirchi; Jari Räsänen; Mark J Krasna; Kaushal Parikh; Kausilia K Krishnadath; Yu Chen; Leonard Griffiths; Benjamin J Colleypriest; J Mark Farrant; David Tosh; Kiron M Das; Manisha Bajpai Journal: Ann N Y Acad Sci Date: 2013-10 Impact factor: 5.691
Authors: Jun Liang Teh; Jin Rong Tan; Linus Jian Fa Lau; Nakul Saxena; Agus Salim; Amy Tay; Asim Shabbir; Sydney Chung; Mikael Hartman; Jimmy Bok-Yan So Journal: Clin Gastroenterol Hepatol Date: 2014-08-10 Impact factor: 11.382
Authors: C F Lacerda; A Cruvinel-Carloni; A T Torres de Oliveira; C Scapulatempo-Neto; R V M López; E Crema; S J Adad; M A M Rodrigues; M A C A Henry; D P Guimarães; R M Reis Journal: Dis Esophagus Date: 2017-04-01 Impact factor: 3.429
Authors: Spiro C Raftopoulos; Dev S Segarajasingam; Valerie Burke; Hooi C Ee; Ian F Yusoff Journal: Am J Gastroenterol Date: 2010-01-12 Impact factor: 10.864
Authors: Mohamed K Kamel; Benjamin Lee; Mohamed Rahouma; Sebron Harrison; Andrew B Nguyen; Jeffrey L Port; Nasser K Altorki; Brendon M Stiles Journal: Eur J Cardiothorac Surg Date: 2018-05-01 Impact factor: 4.191
Authors: Judith J de Jong; Marten A Lantinga; Ina M E Thijs; Philip R de Reuver; Joost P H Drenth Journal: Therap Adv Gastroenterol Date: 2020-11-04 Impact factor: 4.409
Authors: Marcin Romańczyk; Bartosz Ostrowski; Tomasz Marek; Tomasz Romańczyk; Małgorzata Błaszczyńska; Krzysztof Budzyń; Maciej Bugajski; Mateusz Koziej; Maciej Kajor; Krzysztof Januszewski; Wojciech Zajęcki; Marek Waluga; Marek Hartleb Journal: J Gastroenterol Date: 2021-05-02 Impact factor: 6.772